Cancer Research  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 56, 1794-1799, April 15, 1996]
© 1996 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hembree, J. R.
Right arrow Articles by Eckert, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hembree, J. R.
Right arrow Articles by Eckert, R. L.

Retinoid X Receptor-specific Retinoids Inhibit the Ability of Retinoic Acid Receptor-specific Retinoids to Increase the Level of Insulin-like Growth Factor Binding Protein-3 in Human Ectocervical Epithelial Cells1

Joan R. Hembree, Chapla Agarwal, Richard L. Beard, Roshantha A. S. Chandraratna and Richard L. Eckert2

Departments of Physiology and Biophysics [J. R. H., C. A., R. L. E.], Dermatology [R. L. E.], Reproductive Biology [R. L. E.], and Biochemistry [R. L. E.], Case Western Reserve University School of Medicine, Cleveland, Ohio 44106-4970, and Retinoid Research, Departments of Chemistry [R. L. B., R. A. S. C.] and Biology [R. A. S. C], Allergan Incorporated, Irvine, California 92713

The hormones derived from vitamin A and related synthetic ligands (retinoids) are important regulators of differentiation and development and have been shown to be therapeutically useful in the treatment of cervical cancer. All-trans-retinoic acid exerts its effects by activation of retinoic acid receptor (RAR) and retinoid X receptor (RXR) heterodimers. These heterodimers bind to the retinoic acid response elements of target genes to regulate gene expression. RXR ligands act through RXR homodimers to regulate gene expression. In the present study, we describe the effects of RAR- and RXR-specific ligands on the regulation of insulin-like growth factor binding protein-3 (IGFBP-3) production and cell proliferation in human ectocervical epithelial (ECE) cell lines. Treatment of ECE16-1 cells with a RAR-specific ligand (TTNPB) or a ligand that interacts with both RAR and RXR receptors (9-cis-retinoic acid) increases IGFBP-3 levels and suppresses cell proliferation. In contrast, RXR-specific ligands (AGN191701, SR11217, and SR11237) do not regulate proliferation and slightly suppress the IGFBP-3 level. Cotreatment with increasing concentrations (0.01–1000 nm) of RXR-specific ligand antagonizes the growth suppressive and IGFBP-3-increasing effects of 1000 nM TTNPB. Similar results are observed in two other ECE cell lines, ECE16-D1 and ECE16-D2. These results indicate that RXR-specific ligands can antagonize RAR responses in these cell lines and suggest that a RAR-specific retinoid may be superior to one with mixed RAR/RXR binding activity for inhibiting cervical cancer cell proliferation. Moreover, the antagonism of RAR-dependent responses by RXR-specific ligands is consistent with a squelching model in which the RXR-specific ligand drives formation of RXR/RXR homodimers at the expense of the more active RAR/RXR heterodimers.

1 This work was supported by a grant from Allergan Incorporated (to R. L. E.). The American Institute for Cancer Research (to R. L. E.) supported the development of the ECE16-1, ECE16-D1, and ECE16-D2 cell lines, which utilized the facilities of the Skin Diseases Research Center of Northeast Ohio (NIH Grant AR39750). J. R. H. was supported as a postdoctoral trainee in the Metabolism Training Program (NIH Grant DK07319).

2 To whom requests for reprints should be addressed, at Department of Physiology/Biophysics, Room E532, Case Western Reserve University School of Medicine, 2109 Adelbert Road, Cleveland, OH 44106-4970. Phone: (216) 368-5530; Fax: (216) 368-5586.

Received 11/ 2/95. Accepted 2/16/96.




This article has been cited by other articles:


Home page
Endocr. Rev.Home page
S. M. Firth and R. C. Baxter
Cellular Actions of the Insulin-Like Growth Factor Binding Proteins
Endocr. Rev., December 1, 2002; 23(6): 824 - 854.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. F. Sah, R. L. Eckert, R. A. S. Chandraratna, and E. A. Rorke
Retinoids Suppress Epidermal Growth Factor-associated Cell Proliferation by Inhibiting Epidermal Growth Factor Receptor-dependent ERK1/2 Activation
J. Biol. Chem., March 15, 2002; 277(12): 9728 - 9735.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
N. Sueoka, H.-Y. Lee, G. L. Walsh, B. Fang, L. Ji, J. A. Roth, R. LaPushin, W. K. Hong, P. Cohen, and J. M. Kurie
Insulin-Like Growth Factor Binding Protein-6 Inhibits the Growth of Human Bronchial Epithelial Cells and Increases in Abundance with All-trans-Retinoic Acid Treatment
Am. J. Respir. Cell Mol. Biol., September 1, 2000; 23(3): 297 - 303.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
D. Deplewski and R. L. Rosenfield
Role of Hormones in Pilosebaceous Unit Development
Endocr. Rev., August 1, 2000; 21(4): 363 - 392.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Y. Yamanaka, J. L. Fowlkes, E. M. Wilson, R. G. Rosenfeld, and Y. Oh
Characterization of Insulin-Like Growth Factor Binding Protein-3 (IGFBP-3) Binding to Human Breast Cancer Cells: Kinetics of IGFBP-3 Binding and Identification of Receptor Binding Domain on the IGFBP-3 Molecule
Endocrinology, March 1, 1999; 140(3): 1319 - 1328.
[Abstract] [Full Text]


Home page
Biol. Reprod.Home page
C. Agarwal, A. Lambert, R. A.S. Chandraratna, E. A. Rorke, and R. L. Eckert
Vitamin D Regulates Human Ectocervical Epithelial Cell Proliferation and Insulin-Like Growth Factor-Binding Protein-3 Level
Biol Reprod, March 1, 1999; 60(3): 567 - 572.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Cell Physiol.Home page
G. I. Gorodeski, P. Burfeind, S. U. Gan, D. Pal, and F. W. Abdul-Karim
Regulation by retinoids of P2Y2 nucleotide receptor mRNA in human uterine cervical cells
Am J Physiol Cell Physiol, September 1, 1998; 275(3): C758 - C765.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
G. I. Gorodeski, D. Pal, E. A. Rorke, R. L. Eckert, and P. Burfeind
Retinoids modulate P2U purinergic receptor-mediated changes in transcervical paracellular permeability
Am J Physiol Cell Physiol, April 1, 1998; 274(4): C1108 - C1116.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H.-Y. Lee, G. L. Walsh, M. I. Dawson, W. K. Hong, and J. M. Kurie
All-trans-Retinoic Acid Inhibits Jun N-terminal Kinase-dependent Signaling Pathways
J. Biol. Chem., March 20, 1998; 273(12): 7066 - 7071.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
G. I. Gorodeski, R. L. Eckert, D. Pal, W. H. Utian, and E. A. Rorke
Retinoids regulate tight junctional resistance of cultured human cervical cells
Am J Physiol Cell Physiol, November 1, 1997; 273(5): C1707 - C1713.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G.-R. Han, D. F. Dohi, H.-Y. Lee, R. Rajah, G. L. Walsh, W. K. Hong, P. Cohen, and J. M. Kurie
All-trans-retinoic Acid Increases Transforming Growth Factor-beta 2 and Insulin-like Growth Factor Binding Protein-3 Expression through a Retinoic Acid Receptor-alpha -dependent Signaling Pathway
J. Biol. Chem., May 23, 1997; 272(21): 13711 - 13716.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Liu, H.-Y. Lee, S. A. Weinzimer, D. R. Powell, J. L. Clifford, J. M. Kurie, and P. Cohen
Direct Functional Interactions between Insulin-like Growth Factor-binding Protein-3 and Retinoid X Receptor-alpha Regulate Transcriptional Signaling and Apoptosis
J. Biol. Chem., October 20, 2000; 275(43): 33607 - 33613.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1996 by the American Association for Cancer Research.